Insider Transactions in Q3 2025 at Beta Bionics, Inc. (BBNX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,900
-18.35%
|
$207,900
$21.13 P/Share
|
|
Sep 08
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,900
+15.51%
|
$49,500
$5.1 P/Share
|
|
Sep 05
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.23%
|
$2,100
$21.0 P/Share
|
|
Sep 05
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.23%
|
$500
$5.1 P/Share
|
|
Sep 05
2025
|
Mark Hopman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,411
-26.77%
|
$228,220
$20.56 P/Share
|
|
Sep 05
2025
|
Mark Hopman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,411
+21.12%
|
$57,055
$5.1 P/Share
|
|
Sep 04
2025
|
Mark Hopman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,818
-17.93%
|
$129,542
$19.97 P/Share
|
|
Sep 04
2025
|
Mark Hopman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,749
+5.81%
|
$23,745
$5.1 P/Share
|
|
Sep 02
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,462
-3.21%
|
$26,316
$18.86 P/Share
|
|
Sep 02
2025
|
Mark Hopman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
848
-2.48%
|
$15,264
$18.86 P/Share
|
|
Sep 02
2025
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
1,089
-1.17%
|
$19,602
$18.86 P/Share
|
|
Sep 02
2025
|
Steven Jon Russell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,015
-1.41%
|
$18,270
$18.86 P/Share
|
|
Sep 02
2025
|
Sean Saint President & CEO |
SELL
Open market or private sale
|
Direct |
3,359
-3.21%
|
$60,462
$18.86 P/Share
|
|
Aug 22
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,413
-8.84%
|
$75,021
$17.01 P/Share
|
|
Aug 22
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,413
+8.12%
|
$22,065
$5.1 P/Share
|
|
Aug 19
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,587
-10.94%
|
$94,979
$17.03 P/Share
|
|
Aug 19
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,587
+9.86%
|
$27,935
$5.1 P/Share
|
|
Aug 19
2025
|
Mark Hopman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,158
-32.13%
|
$258,528
$16.61 P/Share
|
|
Aug 19
2025
|
Mark Hopman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,158
+24.32%
|
$80,790
$5.1 P/Share
|